Tuesday, July 31, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Dishman Pharmaceuticals & Chemicals Ltd's net profit up by 155%
Economic Times
Dishman is one of the four major Contract Research and Manufacturing Services ( CRAMS) companies in India, engaged mainly into manufacturing of active pharmaceutical ingredients ( API). On Tuesday, Dishman's stock surged by 6.74% closing at Rs ...
See all stories on this topic »
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
MarketWatch (press release)
MALVERN, Pa., July 31, 2012 /PRNewswire via COMTEX/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) , a specialty biopharmaceutical company, today announced financial results for the quarter ending on June 30, 2012. The Company also highlighted ...
See all stories on this topic »
Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
Sacramento Bee
DUBLIN, July 30, 2012 -- /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of Catherine Angell Sohn, Pharm.D., CLP, to its board of directors at the company's annual meeting of shareholders held on July 27, 2012.
See all stories on this topic »
Idenix Pharmaceutical gets Fast Track designation with New Hepititis C Virus ...
Express Pharma
Idenix Pharmaceuticals, the Cambridge-based biotechnology company, announced that its drug, IDX719, was granted a Fast Track designation by the FDA. IDX719, an NS5A inhibitor, is designed to treat chronic hepatitis C virus (HCV) infection in patients.
See all stories on this topic »
Ohr Pharmaceutical Issues Letter to Shareholders
MarketWatch (press release)
NEW YORK, NY, Jul 31, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. (OBB:OHRP) , a pharmaceutical company dedicated to developing novel treatments for large unmet medical needs, issued the following letter to shareholders today: ...
See all stories on this topic »
Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings ...
Seeking Alpha
Tom Marks. Acura Pharmaceuticals (ACUR) Q2 2012 Earnings Call July 31, 2012 8:30 AM ET. Operator. Good day, everyone, and welcome, ladies and gentlemen, to the Acura Pharmaceutical's Conference Call. As a reminder, today's call is being recorded.
See all stories on this topic »
Transcept Pharmaceuticals to Report Second Quarter 2012 Financial Results ...
Sacramento Bee
POINT RICHMOND, Calif., July 30, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic ...
See all stories on this topic »
AmerisourceBergen Signs Three Year Pharmaceutical Supply Agreement with ...
MarketWatch (press release)
"We are honored that Express Scripts has chosen AmerisourceBergen to supply the brand pharmaceuticals it needs for its recently combined mail order and specialty pharmacy business," said Steven H. Collis, AmerisourceBergen President and Chief ...
See all stories on this topic »
Acura Pharmaceuticals Management Discusses Q2 2012 Results - Earnings ...
TheStreet.com
Hologic Management Discusses Q3 2012 Results - Earnings Call Transcript. Good day, everyone, and welcome, ladies and gentlemen, to the Acura Pharmaceutical's Conference Call. As a reminder, today's call is being recorded. [Operator Instructions] At this ...
See all stories on this topic »
Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2012 ...
MarketWatch (press release)
PARSIPPANY, N.J., Jul 31, 2012 (BUSINESS WIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that financial results for the company's second quarter ended June 30, 2012, will be released before the market opens on Thursday, ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, July 30, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin ...
MarketWatch (press release)
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing innovative medicines that selectively target G protein-coupled receptors. Arena is committed to delivering novel treatment options to patients for ...
See all stories on this topic »
Aeolus Pharmaceuticals Announces AEOL 10150 Diminishes Oxidative Stress ...
MarketWatch (press release)
MISSION VIEJO, CA, Jul 30, 2012 (MARKETWIRE via COMTEX) -- Aeolus Pharmaceuticals, Inc. (otcqb:AOLS) (OBB:AOLS) , a biotechnology company leveraging significant government funding to develop a platform of novel compounds in oncology and ...
See all stories on this topic »
Tonix Pharmaceuticals Announces Completion of Clinical Trial of Sublingual ...
MarketWatch (press release)
NEW YORK, Jul 30, 2012 (BUSINESS WIRE) -- Tonix Pharmaceuticals Holding Corp. (OTN:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), ...
See all stories on this topic »
Sunovion Pharmaceuticals Inc. Announces Nationwide Availability of ZETONNA ...
MarketWatch (press release)
MARLBOROUGH, Mass., Jul 30, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced the nationwide availability of ZETONNA(TM) (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), ...
See all stories on this topic »
Simcere Pharmaceutical Group to Announce Second Quarter 2012 Financial ...
MarketWatch (press release)
Simcere Pharmaceutical Group (NYSE:SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development ...
See all stories on this topic »
Somaxon Pharmaceuticals to Report Second Quarter 2012 Results and Conduct ...
MarketWatch (press release)
SAN DIEGO, Jul 30, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it will release its second quarter financial results for the period ended June 30, 2012, ...
See all stories on this topic »
US Hot Stocks: Diebold, Shaw Group, MWI Veterinary Supply
Wall Street Journal (India)
Acura Pharmaceuticals Inc. ($2.03, -$1.05, -34.09%) said Pfizer Inc. (PFE, $23.80, -$0.03, -0.10%) has terminated the license to three development-stage products using the specialty pharmaceutical company's tamper-resistant technology and will return the ...
See all stories on this topic »
Amgen and Idenix Pharmaceuticals Showing Strong Growth -- Biotech Industry ...
Investor's Business Daily
NEW YORK, NY--(Marketwire - Jul 30, 2012) - The Biotechnology Industry has been soaring in 2012 as companies -- both large and small -- have shown impressive growth. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index ETF ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Sunday, July 29, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Doctors' relationships with pharmaceutical companies questioned
West Hartford News
In 2010 and 2011, Dr. Irene Abramovich of West Hartford was the state's top prescriber of Invega, an antipsychotic medication marketed by Janssen Pharmaceuticals. She also was in the top five prescribers of Zyprexa, an antipsychotic marketed by Eli Lilly, ...
See all stories on this topic »
Lupin looks to acquire brands in the US; eyes 20% growth
Economic Times
New Delhi: Drug major Lupin is looking to acquire brands and technology firms to increase reach in the US market as the company aims to grow sales by over 20 per cent in the world's most lucrative drug market over the next two years.
See all stories on this topic »
Investment Insider: Pharmaceutical industry's best years lie ahead
The Independent
Drug developers are finding it harder to come up with new medicines – it is not easy to find a new statin or cholesterol-buster to compete with existing medications. Consequently, companies are forced to go to greater lengths to find new treatments as patents ...
See all stories on this topic »
'Gray market' drug companies hoard pharmaceuticals, net millions, according to ...
Charleston Gazette
CHARLESTON, W.Va. --A new report commissioned in part by Sen. Jay Rockefeller hopes to bring stricter laws to stop price gouging by drug companies that nets hundreds of millions of dollars in profits each year by buying and hoarding desperately needed ...
See all stories on this topic »
GDS International's Fourth Next Generation Pharmaceutical Drug Development ...
Melodika.net (press release)
Combining high-level roundtable discussions with next generation technology solutions that have been specifically tailored to address key topics within the European pharmaceutical sector, workshops from the delegation - as well as from Waters Corporation ...
See all stories on this topic »
Drug-makers take hit as patents lapse
Chicago Daily Herald
Pharmaceutical companies are still very profitable, but that's mainly because they've been on a tear for several years, slashing jobs and closing factories and research centers to cut their costs ahead of what the industry terms the "patent cliff." Virtually every ...
See all stories on this topic »
Julphar announces financial results for first half of 2012
AME Info
It was established in 1980 under the guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah, and is currently a leader in the production and distribution of pharmaceutical products in over 50 countries. Since inception, Julphar ...
See all stories on this topic »

AME Info
Drug makers facing crunch
Cherry Hill Courier Post
TRENTON — Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, adding to the many stresses on the pharmaceutical industry. The Food and Drug Administration approved only 14 ...
See all stories on this topic »
Monroe County Collects Pharmaceutical Waste
13WHAM-TV
Monroe County sponsored a pharmaceutical waste collection to keep dangerous medicines from harming the environment. Organizers say getting rid of the waste benefits everyone. "We really appreciate people coming out and supporting out programs ...
See all stories on this topic »
Concerns Over Quality Of Imported Drugs
Sunday Leader
Last week the State Pharmaceutical Corporation (SPC) and the private pharmaceutical drug importers were at logger heads over the low quality pharmaceutical drugs flooding the local market. This comes in the wake of the Sri Lanka Medical Practitioners ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, July 28, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Pharmaceutical companies cheer as Mormugao Port Trust gets notified port status
Times of India
PANAJI: The pharmaceutical industry in the state has reason to rejoice. The much awaited final notification giving the status of a notified port to Mormugao port has been issued. With this, the doors are now opened for import of pharmaceuticals through Goa's ...
See all stories on this topic »
Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
Sacramento Bee
SOLANA BEACH, Calif., July 27, 2012 -- /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive topically delivered products, announced that Stephen G. Austin, CPA has ...
See all stories on this topic »
Pharmaceutical Manufacturers Attempt to Safeguard Business Continuity from ...
Sacramento Bee
CHAPEL HILL, N.C., July 27, 2012 -- /PRNewswire/ -- Bio-Pharmaceutical and medical device leaders are re-evaluating their crisis management preparation and processes in light of recent major disasters that have disrupted supply chains and global ...
See all stories on this topic »
Acura Pharmaceuticals Announces Update on AVERSION Products
MarketWatch (press release)
About Acura Pharmaceuticals Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary ...
See all stories on this topic »
NPS Pharmaceuticals to Report Second Quarter 2012 Financial Results
MarketWatch (press release)
BEDMINSTER, N.J., Jul 27, 2012 (BUSINESS WIRE) -- NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) announced today that it will report its second quarter 2012 financial results on Wednesday, August 1, 2012 at approximately 4:30 p.m. ET. The press release ...
See all stories on this topic »
PROGENICS PHARMACEUTICALS, INC. : Salix and Progenics Receive ...
4-traders
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals (NASDAQ:PGNX) today received at approximately 5:00 p.m. ET a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following its review of a ...
See all stories on this topic »
Mylan launches generic Sporanox capsules in US
pharmabiz.com
This product is the generic version of Janssen Pharmaceutical Inc.'s Sporanox and is indicated for the treatment of fungal infections that begin in the lungs, blatsomycosis, histoplasmosis, and aspergillosis in patients who are intolerant of or who are refractory ...
See all stories on this topic »
Pfizer to return rights to three Acura products
Economic Times
The pharmaceutical giant will retain rights to Oxecta -- a pain management pill that also uses Acura's technology -- which is already on the market, Acura said. Pfizer will return all assets and regulatory and clinical responsibility related to the three drugs, ...
See all stories on this topic »
ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Patent Docs
American Conference Institute (ACI) will be holding its 13th Annual Maximizing Pharmaceutical Patent Lifecycles conference on October 10-11, 2012 in New York, NY. The conference will allow attendees to: • Understand how the patent cliff will impact ...
See all stories on this topic »
Calls for a rethink on Hormone Replacement Therapy
ABC Online
ELIZABETH JACKSON: The country's health regulator and the pharmaceutical industry are both being asked to help millions of Australian women, whom doctors say are suffering unnecessarily. It's been 10 years since an alarming US study found that ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Friday, July 27, 2012

Google Alert - pharmaceutical news

News7 new results for pharmaceutical news
 
Libor Charges, Online Poker, Par Pharmaceutical: Compliance
Bloomberg
U.S. prosecutors are preparing to file charges this fall against traders from several banks involved in a bid-rigging scheme to manipulate Libor rates, not just Barclays Plc (BARC), according to a person familiar with the case. The charges against individuals, ...
See all stories on this topic »
6 Pharmaceutical Stocks to Buy Now
Investorplace.com
The grades of six Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). Elan (NYSE:ELN) ups its rating to a B ("buy") this week after earning a C ("hold") in the week before.
See all stories on this topic »
Keiretsu Forum Makes its Largest Single Investment to Date in Savara ...
MarketWatch (press release)
"The opportunity to invest in Savara Pharmaceuticals attracted many of our accredited investors, who are deeply committed to supporting products and technologies with the potential to positively impact people's lives," said Randy Williams, Founder and CEO ...
See all stories on this topic »
Sunovion Pharmaceuticals Receives Six Month US Pediatric Exclusivity for ...
MarketWatch (press release)
Sunovion is a leading pharmaceutical company dedicated to discovering, developing and commercializing therapeutic products that advance the science of medicine in the central nervous system (CNS) and respiratory disease areas and improve the lives of ...
See all stories on this topic »
No to demand from pharma cos for insulin price hike: NPPA
Moneycontrol.com
Drug price regulator National Pharmaceutical Pricing Authority has turned down request from major pharma firms, including, Eli Lilly and Biocon, to increase price of insulin used for diabetes treatment. Source: PTI ...
See all stories on this topic »
USFDA lifts ban on Dr Reddy's Laboratories' Mexico plant
Economic Times
... points that Dr Reddy's has submitted," it added. The Mexico facility produces intermediates and active pharmaceutical ingredients. Shares of Dr Reddy's Laboratories today closed at Rs 1621.10 apiece on the BSE, down 0.10 per cent from its previous close.
See all stories on this topic »
NSF International Acquires Becker & Associates Consulting, Inc., a Leading ...
MarketWatch (press release)
Becker will become part of NSF's Health Sciences Division, which offers training and education, consulting, GMP and GLP testing, certification, R&D and auditing services for the pharmaceutical, dietary supplement and medical device industries throughout ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Wednesday, July 25, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Israel's Teva Pharmaceutical Industries to foray into India through JV with Proctor ...
Economic Times
AHMEDABAD: Global pharma giant, Teva Pharmaceutical Industries (TPI) shall foray into India through a joint venture with US based Proctor & Gamble (P&G) and will set up its first manufacturing facility at Sanand in Gujarat, a top state official said here.
See all stories on this topic »
Pharmaceutical boss James Kew 'runs into 11000 volt fallen electric cable while ...
Daily Mail
A pharmaceutical boss has died after 'running into' a high voltage electric cable while jogging with members of his running club. James Kew, 42, who was a top biologist within the research department at GlaxoSmithKline (GSK), is believed to have died ...
See all stories on this topic »

Daily Mail
Government may ease FDI norms in pharmaceutical industry
Economic Times
NEW DELHI: The government is likely to take a less harsh stand on foreign direct investment (FDI) in pharmaceutical companies to ensure a balance between public health concerns and the need to attract investments. An inter-ministerial group set up by the ...
See all stories on this topic »
Biocon close to oral insulin deal with Bristol-Myers Squibb
Economic Times
Four months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bristol-Myers Squibb (BMS), to partner for the development and commercialization of its oral insulin product IN-105, which is ...
See all stories on this topic »
BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ ...
MarketWatch (press release)
NOVATO, Calif., Jul 25, 2012 (GlobeNewswire via COMTEX) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin's board of directors approved the grant to two employees of ...
See all stories on this topic »
TEXT-Fitch:Global pharmaceutical approvals moderate as patent cliff peaks
Reuters
July 25 - Fitch Ratings expects the Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 as compared to 2011 while the industry faces several ongoing operational risks, according to a new report. Fitch believes that the total of 30 new ...
See all stories on this topic »
Salix Pharmaceuticals Announces 2Q2012 Financial Results Conference Call ...
MarketWatch (press release)
RALEIGH, N.C., Jul 25, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report second quarter 2012 financial results following the close of the U.S. financial markets on Wednesday, August 8, ...
See all stories on this topic »
Antitrust: Commission enforcement action in pharmaceutical sector following ...
eGov monitor
Following its competition inquiry into the pharmaceutical sector of 2008/2009 (see IP/09/1098 and MEMO/09/321) the European Commission has issued a statement of objections against Lundbeck and other pharmaceutical companies in a major investigation ...
See all stories on this topic »
Acura Pharmaceuticals to Host Second Quarter 2012 Financial Results ...
MarketWatch (press release)
PALATINE, IL, Jul 25, 2012 (MARKETWIRE via COMTEX) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the company plans to report financial results for the ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, July 24, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Calif. county to vote on medication disposal bill
Businessweek
(AP) — A proposed ordinance that would put the pharmaceutical industry on the hook for not only making drugs, but also getting rid of them, is scheduled to be taken up by California's Alameda County on Tuesday. The Alameda County Board of Supervisors ...
See all stories on this topic »
Ritter Pharmaceuticals Appoints Michael Step to the Board of Directors
MarketWatch (press release)
LOS ANGELES, CA, Jul 24, 2012 (MARKETWIRE via COMTEX) -- Ritter Pharmaceuticals, Inc. (Ritter Pharma) has appointed Michael Step to its Board of Directors. Mr. Step brings over 20 years of corporate development experience in the biotechnology and ...
See all stories on this topic »
Collegium Pharmaceutical Announces the Appointment of Gino Santini to Board ...
MarketWatch (press release)
CUMBERLAND, R.I., Jul 24, 2012 (BUSINESS WIRE) -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce the appointment of Gino Santini to its ...
See all stories on this topic »
CURE Pharmaceutical to Begin Clinical Trials with PediaSUNATE(TM)
MarketWatch (press release)
CURE Pharmaceutical is a preeminent developer and manufacturer of the most advanced oral thin film (OTF) on the market today with an industry leading full service cGMP manufacturer. CURE offers the most advanced development and manufacturing of ...
See all stories on this topic »
BMGI Presents the Elixir for Transforming Indian Pharmaceutical Industry to ...
Moneylife Personal Finance site and magazine
As the key knowledge partner for India Pharmaceutical Summit 2012, held in the Hilton Mumbai International Airport Hotel, Mumbai on 12th & 13th July, BMGI presented the 'elixir' for making India the top Pharmerging market in the world. The event was ...
See all stories on this topic »
Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on ...
MarketWatch (press release)
DUBLIN, Calif., Jul 24, 2012 (GlobeNewswire via COMTEX) -- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its ...
See all stories on this topic »
PMO to take final view on relaxing FDI in pharma: Official
Economic Times
NEW DELHI: Prime Minister's Office (PMO) will take a final view on relaxing foreign direct investment norms in the pharmaceutical sector, a senior Finance Ministry official said today. "We have reached a final consensus on approvals to the FDI proposals in ...
See all stories on this topic »
Alameda County considers making drug companies pay for getting rid of unused ...
Washington Post
"It would be sort of like Boston asking rice farmers in central California valley to pay the cost of garbage disposal because the trash has rice in it," Marjorie Powell, a representative of Pharmaceutical Research and Manufacturers of America, said Monday.
See all stories on this topic »
Dr Reddy's Laboratories' sales may be hit as countries attempt to cut costs
Economic Times
Patient Protection and Affordable Care Act (PPACA) of USA is one of the most significant healthcare reform measures in the United States in decades, and is expected to significantly impact the US pharmaceutical industry, it said. The PPACA changed the ...
See all stories on this topic »
California county to vote on drug disposal bill
USA TODAY
Updated. Comments. OAKLAND, Calif. (AP) – A proposed county ordinance in Northern California puts the pharmaceutical industry on the hook for not only making drugs, but also getting rid of them.
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost